Clinical Trial Update: Perioperative Immunotherapy for NSCLC (ECTOP-1030) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for perioperative immunotherapy in non-small cell lung cancer (ECTOP-1030), currently not yet recruiting; sponsor is Fudan Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING